البلد: أرمينيا
اللغة: الإنجليزية
المصدر: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
ramipril
Brupharmexport SPRL
ramipril
10mg
capsules
Prescription
PACKAGE LEAFLET: INFORMATION FOR THE USER BRUMIPRIL 2.5 MG - 5 MG - 10 MG CAPSULES Ramipril Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If any of the side effects become serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. WHAT IS IN THIS LEAFLET: 1. What BRUMIPRIL is and what it is used for 2. Before taking BRUMIPRIL 3. How to take BRUMIPRIL 4. Possible side effects 5. How to store BRUMIPRIL 6. Further information 1. WHAT BRUMIPRIL IS AND WHAT IT IS USED FOR BRUMIPRIL contains an active substance known as ramipril. Ramipril belongs to a group of medicines called "ACE Inhibitors" (angiotensin-converting enzyme inhibitors). BRUMIPRIL acts by: . Promoting the reduction of production by your body of substances which increase your blood pressure . Promoting the relaxation and enlargement of your blood vessels . Making it easier for your heart to pump blood to the entire body BRUMIPRIL can be used for: . Treating high blood pressure (hypertension) . Reducing the risk of heart attack or stroke . Reducing the risk or delaying the aggravation of kidney problems (whether you are diabetic or not) . Treating the heart when it is unable to pump sufficient blood to the rest of your body (heart failure) . Treatment following a heart attack (myocardial infarction) when complicated by heart failure 2. BEFORE TAKING BRUMIPRIL DO NOT TAKE BRUMIPRIL - If you are allergic (hypersensitive) to ramipril, other ACE inhibitory medicines or any other ingredients of BRUMIPRIL (see section 6) The signs of allergic reactions can include rash, difficulty in swallowing or breathing, swelling of your lips, face, throat or tongue. - If you have ever had a severe allergic reaction called "angio اقرأ الوثيقة كاملة
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT BRUMIPRIL 2.5 mg BRUMIPRIL 5 mg BRUMIPRIL 10 mg 2. QUALITATIVE AND QUANTITATIVE COMPOSITION BRUMIPRIL 2.5 mg Each capsule contains 2.5 mg of ramipril. BRUMIPRIL 5 mg Each capsule contains 5 mg of ramipril. BRUMIPRIL 10 mg Each capsule contains 10 mg of ramipril. Complete list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Capsule. BRUMIPRIL 2.5 mg, Capsule: size 4 capsule, pale grey colour body and pale green cap, containing a white or off-white powder. BRUMIPRIL 5 mg, Capsule: size 4 capsule, pale grey colour body and green cap, containing a white or off- white powder. BRUMIPRIL 10 mg, Capsule: size 4 capsule, pale grey colour body and dark green cap, containing a white or off-white powder. 1 4. CLINICAL PARTICULARS 4.1 Therapeutic indications - Treatment of hypertension. - Cardiovascular prevention: reduction of cardiovascular morbidity and mortality in patients with: - manifest atherothrombotic cardiovascular disease (history of coronary heart disease or cerebrovascular accident (stroke) or peripheral vascular disease); or - diabetes associated to at least one cardiovascular risk factor (see section 5.1). - Treatment of renal disease: - Incipient diabetic glomerular nephropathy as defined by the presence of microalbuminuria, - Clinically manifest diabetic glomerular nephropathy as defined by the presence of macroproteinuria in patients with at least one cardiovascular risk factor (see section 5.1), - Clinically manifest non-diabetic glomerular nephropathy, defined by the presence of macroproteinuria ≥ 3 g/day (see section 5.1). - Treatment of symptomatic heart failure. - Secondary prevention following acute myocardial infarction: reduction of mortality following the acute phase of the myocardial infarction in patients with clinical signs of heart failure starting over 48 hours after an acute myocardial infarction. 4.2 Posology and method of administration Oral route. The recommended administration of BRUMIPRIL is a single daily dose, اقرأ الوثيقة كاملة